These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2664204)

  • 41. Two cases of clonidine abuse/dependence in methadone-maintained patients.
    Lauzon P
    J Subst Abuse Treat; 1992; 9(2):125-7. PubMed ID: 1512800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome.
    Smolka M; Schmidt LG
    Addiction; 1999 Aug; 94(8):1191-8. PubMed ID: 10615734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The development of a Short Opiate Withdrawal Scale (SOWS).
    Gossop M
    Addict Behav; 1990; 15(5):487-90. PubMed ID: 2248123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.
    Cucchia AT; Monnat M; Spagnoli J; Ferrero F; Bertschy G
    Drug Alcohol Depend; 1998 Nov; 52(3):243-50. PubMed ID: 9839150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2003; (2):CD003409. PubMed ID: 12804464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
    Agren H
    Acta Psychiatr Scand Suppl; 1986; 327():91-113. PubMed ID: 3529831
    [No Abstract]   [Full Text] [Related]  

  • 48. Levels of opioid physical dependence in heroin addicts.
    Kanof PD; Aronson MJ; Ness R; Cochrane KJ; Horvath TB; Handelsman L
    Drug Alcohol Depend; 1991 May; 27(3):253-62. PubMed ID: 1884668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonidine blocks acute opiate-withdrawal symptoms.
    Gold MS; Redmond DE; Kleber HD
    Lancet; 1978 Sep; 2(8090):599-602. PubMed ID: 80526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of clonidine in opiate withdrawal: a study of thirty patients.
    Gold MS; Pottash AL; Sweeney DR; Kleber HD
    Drug Alcohol Depend; 1980 Oct; 6(4):201-8. PubMed ID: 7023893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind, placebo-controlled trial of dextromethorphan combined with clonidine in the treatment of heroin withdrawal.
    Lin SK; Pan CH; Chen CH
    J Clin Psychopharmacol; 2014 Aug; 34(4):508-12. PubMed ID: 24875077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial.
    Ornish SA; Zisook S; McAdams LA
    Arch Intern Med; 1988 Sep; 148(9):2027-31. PubMed ID: 3046542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Hensel M; Kox WJ
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of heroin withdrawal with guanfacine: an open clinical investigation.
    Soler Insa PA; Bedate Villar J; Theohar C; Yotis A
    Can J Psychiatry; 1987 Nov; 32(8):679-82. PubMed ID: 2891431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children.
    Capino AC; Miller JL; Johnson PN
    Pharmacotherapy; 2016 Dec; 36(12):1290-1299. PubMed ID: 27779775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self-detoxification by opiate addicts. A preliminary investigation.
    Gossop M; Battersby M; Strang J
    Br J Psychiatry; 1991 Aug; 159():208-12. PubMed ID: 1663410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Naltrexone shortened opioid detoxification with buprenorphine.
    Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
    Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonidine in opiate withdrawal: review and appraisal of clinical findings.
    Washton AM; Resnick RB
    Pharmacotherapy; 1981; 1(2):140-6. PubMed ID: 6765486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.